These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3180109)
41. [Regulation of food intake and appetite: overview]. Aou S; Suzuki K; Oomura Y Nihon Rinsho; 1995 Jun; 53 Suppl():13-8. PubMed ID: 7563674 [No Abstract] [Full Text] [Related]
42. Higher-Order Inputs Involved in Appetite Control. Azevedo EP; Ivan VJ; Friedman JM; Stern SA Biol Psychiatry; 2022 May; 91(10):869-878. PubMed ID: 34593204 [TBL] [Abstract][Full Text] [Related]
43. Phlorizin inhibition of hypothalamic necrosis induced by gold thioglucose. Debons AF; Krimsky I; From A; Pattinian H Am J Physiol; 1974 Mar; 226(3):574-8. PubMed ID: 4593806 [No Abstract] [Full Text] [Related]
44. [Hyperphagia and hepatic steatosis in the goose after lesion of the ventromedial nuclleus of the hypothalamus]. Auffray P; Blum JC C R Acad Hebd Seances Acad Sci D; 1970 May; 270(19):2362-5. PubMed ID: 4997615 [No Abstract] [Full Text] [Related]
45. Serotonin, a major player in the regulation of feeding and affect. Casper RC Biol Psychiatry; 1998 Nov; 44(9):795-7. PubMed ID: 9807635 [No Abstract] [Full Text] [Related]
46. PSYCHOLOGY of eating. Br Med J; 1953 Mar; 1(4810):613-4. PubMed ID: 13019150 [No Abstract] [Full Text] [Related]
47. The viable serotonin hypothesis. Li ET Nutr Rev; 1992 Jul; 50(7):214-5. PubMed ID: 1641204 [No Abstract] [Full Text] [Related]
48. Elucidating the Role of Peripheral Neurotensin in Appetite Control. Izaguirre M; Catalán V; Frühbeck G Endocrinology; 2016 Sep; 157(9):3391-3. PubMed ID: 27580805 [No Abstract] [Full Text] [Related]
49. Interplay between Peripheral and Central Inflammation in Obesity-Promoted Disorders: The Impact on Synaptic Mitochondrial Functions. Crispino M; Trinchese G; Penna E; Cimmino F; Catapano A; Villano I; Perrone-Capano C; Mollica MP Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825115 [TBL] [Abstract][Full Text] [Related]
50. Obesity: Current and potential pharmacotherapeutics and targets. Narayanaswami V; Dwoskin LP Pharmacol Ther; 2017 Feb; 170():116-147. PubMed ID: 27773782 [TBL] [Abstract][Full Text] [Related]
52. Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa. Avena NM; Bocarsly ME Neuropharmacology; 2012 Jul; 63(1):87-96. PubMed ID: 22138162 [TBL] [Abstract][Full Text] [Related]
54. Present and future: pharmacologic treatment of obesity. Glandt M; Raz I J Obes; 2011; 2011():636181. PubMed ID: 21331293 [TBL] [Abstract][Full Text] [Related]
55. The use of lorcaserin in the management of obesity: a critical appraisal. Bai B; Wang Y Drug Des Devel Ther; 2010 Dec; 5():1-7. PubMed ID: 21267355 [TBL] [Abstract][Full Text] [Related]
56. Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice. Line SJ; Barkus C; Coyle C; Jennings KA; Deacon RM; Lesch KP; Sharp T; Bannerman DM Eur Neuropsychopharmacol; 2011 Jan; 21(1):108-16. PubMed ID: 20863670 [TBL] [Abstract][Full Text] [Related]
57. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. Calapai G; Corica F; Corsonello A; Sautebin L; Di Rosa M; Campo GM; Buemi M; Mauro VN; Caputi AP J Clin Invest; 1999 Oct; 104(7):975-82. PubMed ID: 10510338 [TBL] [Abstract][Full Text] [Related]
58. Effects of electromagnetic fields on the levels of biogenic amine metabolites, quinolinic acid, and beta-endorphin in the cerebrospinal fluid of dairy cows. Burchard JF; Nguyen DH; Richard L; Young SN; Heyes MP; Block E Neurochem Res; 1998 Dec; 23(12):1527-31. PubMed ID: 9821157 [TBL] [Abstract][Full Text] [Related]
59. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Pijl H; Meinders AE Drug Saf; 1996 May; 14(5):329-42. PubMed ID: 8800628 [TBL] [Abstract][Full Text] [Related]